FDAnews
www.fdanews.com/articles/205364-tectraums-pro2cool-concussion-treatment-designated-a-breakthrough-device

TecTraum’s pro2cool Concussion Treatment Designated a Breakthrough Device

November 16, 2021

Cleveland, Ohio-based TecTraum has received the FDA’s Breakthrough Device designation for its pro2cool system for concussion care.

The noninvasive hypothermic therapy device is designed to reduce the severity of concussion symptoms and allow patients to recover more quickly.   

The device provides localized cooling for the head and neck to lower blood temperature before it enters the brain. Research has shown that cooling the brain within days of a concussion significantly improves clinical outcomes, the company said.

View today's stories